The rush to reach maximum doses provides little benefit compared to tolerating lower doses comfortably for longer periods
FDA or the European Medicines Agency
Aratrmalar, bu peptidin zellikle hasar grm dokularn onarm srecini hzlandrabileceini gstermektedir
Simonetti O, Cirioni O, Goteri G, Lucarini G, Kamysz E, Kamysz W
National Institutes of Healht
Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin At a glance BPC-157 half-life / approximately 4 hours (subcutaneous or intramuscular) TB-500 half-life / longer systemic distribution, dosed 2-4 mg twice weekly IGF-1 LR3 active window / up to 20 hours vs ~20 minutes for native IGF-1 Semax mechanism / upregulates BDNF and dopamine receptor sensitivity Selank mechanism / enhances GABA-A tone and reduces IL-6 by ~30% in animal models GHRP-2 GH pulse / strong but co-elevates cortisol and prolactin Ipamorelin GH pulse / selective